In vitro and in silico study on the effect of carvedilol and sorafenib alone and in combination on the growth and inflammatory response of melanoma cells

Melanoma is an aggressive skin cancer. Increasing evidence has shown the role of β-adrenergic receptors in the pathogenesis of melanoma. Carvedilol is a widely used non-selective β-AR antagonist with potential anticancer activity. The purpose of the study was to estimate the influence of carvedilol...

Descripción completa

Detalles Bibliográficos
Autores principales: Wawszczyk, Joanna, Wolan, Radosław, Smolik, Sławomir, Kapral, Małgorzata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265481/
https://www.ncbi.nlm.nih.gov/pubmed/37323921
http://dx.doi.org/10.1016/j.jsps.2023.05.020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265481/
https://www.ncbi.nlm.nih.gov/pubmed/37323921
http://dx.doi.org/10.1016/j.jsps.2023.05.020

Ejemplares similares